SWAV
Income statement / Annual
Last year (2023), ShockWave Medical, Inc.'s total revenue was $730.23 M,
an increase of 49.11% from the previous year.
In 2023, ShockWave Medical, Inc.'s net income was $147.28 M.
See ShockWave Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$730.23 M
|
$489.73 M
|
$237.15 M
|
$67.79 M
|
$42.93 M
|
$12.26 M
|
$1.72 M
|
| Cost of Revenue |
$95.39 M |
$65.00 M |
$41.44 M |
$20.99 M |
$17.16 M |
$7.25 M |
$2.84 M |
| Gross Profit |
$634.84 M |
$424.74 M |
$195.71 M |
$46.80 M |
$25.77 M |
$5.01 M |
-$1.12 M |
| Gross Profit Ratio |
0.87 |
0.87 |
0.83 |
0.69 |
0.6 |
0.41 |
-0.65 |
| Research and Development
Expenses |
$145.65 M
|
$81.68 M
|
$50.54 M
|
$36.93 M
|
$32.85 M
|
$22.70 M
|
$17.96 M
|
| General & Administrative
Expenses |
$95.27 M
|
$56.93 M
|
$34.75 M
|
$23.86 M
|
$14.13 M
|
$5.98 M
|
$5.42 M
|
| Selling & Marketing
Expenses |
$234.84 M
|
$162.00 M
|
$111.29 M
|
$51.67 M
|
$30.62 M
|
$17.54 M
|
$6.36 M
|
| Selling, General &
Administrative Expenses |
$323.20 M
|
$218.92 M
|
$146.04 M
|
$75.54 M
|
$44.75 M
|
$23.52 M
|
$11.79 M
|
| Other Expenses |
$23.96 M |
$1.06 M |
-$582,000.00 |
$1.26 M |
$2.35 M |
$589,000.00 |
$366,000.00 |
| Operating Expenses |
$468.85 M |
$300.60 M |
$196.58 M |
$112.46 M |
$77.61 M |
$46.21 M |
$29.75 M |
| Cost And Expenses |
$564.24 M |
$365.60 M |
$238.02 M |
$133.45 M |
$94.77 M |
$53.46 M |
$32.58 M |
| Interest Income |
$0.00 |
$1.89 M |
$1.10 M |
$1.21 M |
$944,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$6.20 M |
$1.89 M |
$1.10 M |
$1.21 M |
$944,000.00 |
$401,000.00 |
$58,000.00 |
| Depreciation &
Amortization |
$10.36 M
|
-$1.42 M
|
-$6.87 M
|
$1.26 M
|
$2.35 M
|
$700,000.00
|
$468,000.00
|
| EBITDA |
$176.35 M
|
$127.57 M
|
-$871,000.00
|
-$62.32 M
|
-$49.56 M
|
-$39.91 M
|
-$30.03 M
|
| EBITDA Ratio |
0.24 |
0.25 |
-0.03 |
-0.95 |
-1.15 |
-3.25 |
-17.47 |
| Operating Income Ratio
|
0.23
|
0.25
|
-0
|
-0.97
|
-1.21
|
-3.36
|
-17.96
|
| Total Other
Income/Expenses Net |
$8.29 M
|
-$3.31 M
|
-$7.96 M
|
$44,000.00
|
$792,000.00
|
$136,000.00
|
$276,000.00
|
| Income Before Tax |
$174.28 M |
$120.83 M |
-$8.84 M |
-$65.62 M |
-$51.05 M |
-$41.06 M |
-$30.59 M |
| Income Before Tax Ratio
|
0.24
|
0.25
|
-0.04
|
-0.97
|
-1.19
|
-3.35
|
-17.79
|
| Income Tax Expense |
$27.00 M |
-$95.17 M |
$301,000.00 |
$80,000.00 |
$62,000.00 |
$38,000.00 |
$26,000.00 |
| Net Income |
$147.28 M |
$216.00 M |
-$9.14 M |
-$65.70 M |
-$51.11 M |
-$41.10 M |
-$30.62 M |
| Net Income Ratio |
0.2 |
0.44 |
-0.04 |
-0.97 |
-1.19 |
-3.35 |
-17.81 |
| EPS |
4.01 |
6.02 |
-0.26 |
-1.99 |
-2.14 |
-1.53 |
-1.57 |
| EPS Diluted |
3.85 |
5.7 |
-0.26 |
-1.99 |
-2.14 |
-1.53 |
-1.57 |
| Weighted Average Shares
Out |
$36.71 M
|
$35.90 M
|
$35.10 M
|
$33.09 M
|
$23.90 M
|
$26.91 M
|
$19.53 M
|
| Weighted Average Shares
Out Diluted |
$38.21 M
|
$37.88 M
|
$35.10 M
|
$33.09 M
|
$23.90 M
|
$26.91 M
|
$19.53 M
|
| Link |
|
|
|
|
|
|
|
